When is treatment for cancer economically justified? Discussion paper.
Jennett
B
B
Department of Neurosurgery, Institute of Neurological Sciences, Glasgow.
Buxton
M
M
D003362:Cost-Benefit Analysis; D004467:Economics; D006295:Health Resources / Q000191:economics; D006801:Humans; D009369:Neoplasms / Q000191:economics / Q000628:therapy*; D011379:Prognosis; D011788:Quality of Life; D013673:Technology Assessment, Biomedical; D006113:United Kingdom; D026712:Value of Life